10-Q: Axcelis Q3 Earnings Decline Amid Veeco Merger Plans

Axcelis Technologies reported a significant drop in Q3 2025 revenue and net income, while announcing a definitive merger agreement with Veeco Instruments Inc. expected to close in late 2026.

Summary

• Total revenue for the three months ended September 30, 2025, decreased by 16.7% to $213.6 million from $256.6 million in the prior year period.
• Net income for the three months ended September 30, 2025, fell by 46.5% to $26.0 million ($0.83 diluted EPS) from $48.6 million ($1.49 diluted EPS) in the same period of 2024.
• For the nine months ended September 30, 2025, total revenue decreased by 21.5% to $600.7 million from $765.4 million in the prior year period.
• Net income for the nine months ended September 30, 2025, decreased by 43.1% to $85.9 million ($2.70 diluted EPS) from $151.0 million ($4.61 diluted EPS) in the same period of 2024.
• The company entered into a definitive Agreement and Plan of Merger with Veeco Instruments Inc. on September 30, 2025, under which Veeco will become a wholly-owned subsidiary of Axcelis.
• Veeco stockholders will receive 0.3575 newly issued shares of Axcelis common stock for each share of Veeco common stock.
• The merger is subject to customary closing conditions, including stockholder and regulatory approvals, and is expected to close in the second half of 2026.
• Cash and cash equivalents increased to $187.5 million at September 30, 2025, from $123.5 million at December 31, 2024.
• The company repurchased 1.5 million shares of common stock for $95.9 million at an average cost of $62.33 per share during the nine months ended September 30, 2025.

Sentiment

Score: 4

Explanation: The filing presents a mixed outlook. While financial performance for the quarter and nine-month period shows significant declines in revenue and profitability, the announcement of a strategic merger with Veeco Instruments Inc. introduces a transformative element. The company maintains a strong cash position and continues its share repurchase program. However, the immediate financial results are concerning, and the merger introduces substantial execution and integration risks.

Positives

• Services revenue increased by 27.3% for the three months and 11.6% for the nine months ended September 30, 2025, indicating strength in aftermarket support.
• Net cash provided by investing activities significantly improved, generating $37.2 million for the nine months ended September 30, 2025, compared to a usage of $117.8 million in the prior year, primarily due to maturities and sales of short-term investments.
• Cash and cash equivalents increased by $64.0 million to $187.5 million, maintaining a strong liquidity position.
• The company continues its share repurchase program, with $135 million remaining authorized for future repurchases as of September 30, 2025, demonstrating commitment to shareholder returns.
• Gross margin from product revenue for the nine months ended September 30, 2025, increased to 46.8% from 45.8% in the prior year, driven by a favorable mix of system shipments and higher-margin parts and upgrades.

Negatives

• Total revenue decreased by 16.7% for the three months and 21.5% for the nine months ended September 30, 2025, primarily due to a decrease in system sales.
• Net income declined sharply by 46.5% for the three months and 43.1% for the nine months ended September 30, 2025, reflecting lower revenue and gross profit.
• Diluted earnings per share decreased by 44.3% for the three months and 41.4% for the nine months ended September 30, 2025.
• Gross profit decreased by 19.2% for the three months and 21.7% for the nine months ended September 30, 2025, with overall gross margin slightly down.
• Income from operations decreased by 46.7% for the three months and 46.8% for the nine months ended September 30, 2025.
• Inventories, net, increased by $42.1 million to $324.3 million at September 30, 2025, from $282.2 million at December 31, 2024, which could indicate slower sales or increased production ahead of demand.
• Net cash used in financing activities increased to $99.9 million for the nine months ended September 30, 2025, from $56.6 million in the prior year, largely due to higher share repurchases.

Risks

• The proposed merger with Veeco Instruments Inc. is subject to significant conditions, including stockholder and regulatory approvals, which may not be satisfied or completed in a timely manner, or at all.
• Failure to complete the merger could lead to a decline in the company's common stock market price, substantial termination fees ($108.7 million for Axcelis), and negative reactions from financial markets, customers, suppliers, and employees.
• Delays in completing the merger could result in additional transaction costs, loss of revenue, and other negative effects associated with uncertainty.
• Regulatory authorities may impose conditions on merger approval that could significantly reduce the anticipated benefits, including synergies, or adversely affect the combined company's business.
• Uncertainties associated with the merger may cause a loss of management personnel and other key employees, and the company may face difficulties attracting and motivating talent.
• Customer concentration risk exists, with one customer accounting for 11.9% of total revenue for the three months and 10.6% for the nine months ended September 30, 2025, and two customers accounting for 12.7% and 10.2% of accounts receivable.
• The company operates in a highly technical and competitive semiconductor industry, requiring continuous investment in R&D to develop new technologies and products, which may not always be successful or timely.
• Global economic conditions, including tariff programs and geopolitical environments, could impact customer capital spending patterns and the company's financial results.
• The company's ability to obtain U.S. export control licenses for sales to customers in China could be impacted by regulations like the Affiliates Rule, potentially affecting China-based revenues.

Future Outlook

The company anticipates the merger with Veeco Instruments Inc. to close in the second half of 2026, subject to various approvals. Management is evaluating the full impact of recent accounting guidance (ASU 2023-09, 2024-03, 2025-06, 2025-07) on future financial statements and disclosures. The geopolitical environment surrounding trade and tariffs is not currently anticipated to have a material impact on China-based revenues, but the company continues to develop plans to mitigate potential impacts.

Management Comments

• "Management believes that maintaining a strong cash balance is necessary to fund a continuing ramp in our business which can require significant cash investment to meet sudden demand."
• "We continue to evaluate this rule [the Affiliates Rule] and its potential impact on our business, but based on our preliminary review, we currently do not anticipate it to have a material impact to our China-based revenues."
• "Sales of our systems in the first nine months of 2025 were down compared to the same period in the prior year, as customers have moderated the pace of investments into mature process node technologies."

Industry Context

The semiconductor manufacturing industry is experiencing consolidation and a moderation in customer investments, particularly in mature process node technologies, which impacted Axcelis's system sales. The company's focus on ion implantation equipment and aftermarket services positions it within a specialized segment of the broader semiconductor equipment market. The proposed merger with Veeco Instruments Inc. reflects a strategic move towards further consolidation and potential expansion within the industry.

Legal Proceedings

• The company is from time to time a party to litigation that arises in the normal course of business operations, but is not presently a party to any litigation believed to have a material adverse effect on business operations.

Stakeholder Impact

• Shareholders: Potential for significant share price volatility due to the merger announcement and declining financial performance. Veeco shareholders will receive Axcelis common stock, potentially leading to dilution for existing Axcelis shareholders. The share repurchase program aims to return value to shareholders.
• Employees: Uncertainty regarding roles and potential changes within the combined company following the merger, which could affect retention and attraction of key personnel.
• Customers: Potential for negative reactions or disruptions to relationships due to the merger, although the combined entity aims to offer enhanced capabilities.
• Suppliers: Similar to customers, relationships could be impacted by the merger announcement and integration process.
• Creditors: The company maintains a strong cash balance and liquidity, which should reassure creditors despite the financial downturn and merger-related costs.

Next Steps

• Proceed with the merger process with Veeco Instruments Inc., including obtaining stockholder and regulatory approvals.
• Continue to evaluate the full impact of new accounting standards (ASU 2023-09, 2024-03, 2025-06, 2025-07) on future consolidated financial statements and disclosures.
• Monitor and adapt to changes in the geopolitical environment, including trade and tariff policies, and their potential impact on China-based revenues.
• Continue to execute the share repurchase program, with $135 million remaining authorized.

Key Dates

Recommendation

The significant decline in revenue and net income for both the quarter and year-to-date periods indicates a challenging operational environment, primarily driven by moderated customer investments in mature process node technologies. However, the announcement of a strategic merger with Veeco Instruments Inc. is a transformative event that could reshape the company's future competitive landscape and growth trajectory. Given the immediate financial headwinds and the substantial uncertainties and risks associated with a large-scale merger (regulatory approvals, integration challenges, potential termination fees), a 'hold' recommendation is prudent. Investors should await further clarity on the merger's progress, integration plans, and the combined entity's financial outlook before making definitive buy or sell decisions. The strong cash position and ongoing share repurchase program provide some stability, but the near-term outlook is clouded by operational declines and merger-related complexities.

Keywords

Axcelis Technologies, Veeco Instruments, semiconductor equipment, ion implantation, Q3 2025 earnings, merger agreement, financial results, stock repurchase, semiconductor industry, revenue decline, net income decrease, corporate merger, regulatory approval, risk factors